MAR 13, 2018 12:43 PM PDT
Enzyme's Structure Linked to Heart Disease, Diabetes, Cancer, Parkinson's
WRITTEN BY: Kara Marker
3 7 388

One enzyme’s structure may hold the key to new treatments for a variety of diseases: diabetes, cancer, neurodegenerative disorders, heart disease. Without knowing its structure, researchers have not been successful in developing inhibitor drugs to address the protein’s connection to various conditions through activating the inflammatory pathway. Now, from St. Louis University, scientists have been able to determine the enzyme’s structure.

Photomicrograph of a region of substantia nigra in a Parkinson's patient showing Lewy bodies and Lewy neurites. Credit: Suraj Rajan

"In the past, people have studied this complex enzyme, like a black box, without knowing what is inside," explained Sergey Korolev, PhD. "Now that we have discovered the structure, we can see every atom. This allows us to visualize what is happening with this protein. It is a completely new level of insight."

The enzyme is calcium-independent phospholipase A2β (iPLA2β), which was first discovered more than 20 years ago for its role in type 1 diabetes, then again ten years ago for its role in neurodegenerative disorders. In addition to “iPLA2β,” the enzyme is also referred to as PARK14 in connection to genetic mutations in patients with Parkinson’s disease.

“For example, inherited mutations in this gene were identified in patients with early onset Parkinson's,” Korolev explained.

Korolev and many other scientists are interested in iPLA2β because of its connection to the inflammatory response, a mechanism known to be at the foundation of multiple diseases. Past studies show that iPLA2β cleaves phospholipids in the cell membrane and responds to injury by triggering the immune response.

But without knowing iPLA2β’s molecular structure, researchers couldn’t answer important questions: How is iPLA2β activated during injury? How does it get shut down (deactivating the inflammatory response)?

Korolev and other scientists from St. Louis University were finally able to determine iPLA2β’s molecular structure via x-ray crystallography. What they found was different than what researchers had anticipated.

"Before we had the structure, people didn't have good tools to study this enzyme," Korolev said. “Now, the 3D structure gives us a clear hypothesis for how it is responsible for action in different cellular compartments and tissues.”

"There is a growing amount of genetic work that links iPLA2β to neurodegenerative disease, and physicians and scientists worldwide are now interested in its function," explained MD/PhD student Konstantin Malley. "We are still a long way from treating patients, but I would like them to know that the structure is a large step between genetics and developing targeted therapies for treatment.”

The present study was published in the journal Nature Communications.

Sources: St. Louis University, Diabetes

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 13, 2018
Immunology
FEB 13, 2018
Bed Bugs: More Than Just A Nuisance
As if bed bugs weren’t irritating enough, researchers have now associated the pests with dangerously high levels of histamine. In a new study from No
MAR 06, 2018
Health & Medicine
MAR 06, 2018
Are We Ready For a Smallpox Outbreak?
There's no question that if smallpox were to reappear, it would be a global health emergency. While it was eradicated in 1980, last year Canadian scien
APR 02, 2018
Immunology
APR 02, 2018
How does Johne's disease evade the immune system?
An infectious disease that afflicts cattle all over the world is particularly devastating because it can inhibit the animals’ immune systems. In a ne
APR 11, 2018
Immunology
APR 11, 2018
Gene Editing Tools Reveal Two Key Genes Involved in Influenza Infection
Using CRISPR/Cas9 gene editing tools, researchers identified two genes responsible for suppressing the immune system and allowing the influenza virus to in
JUN 01, 2018
Immunology
JUN 01, 2018
How does estrogen increase the risk of autoimmunity for women?
The unique activity of estrogen hormones and their cell receptors in the female body may explain why women are more likely than men to develop autoimmune d
JUN 04, 2018
Immunology
JUN 04, 2018
Asthma and Flu Make A Deadly Combination
When someone with a cold or the flu also has an asthma attack, the situation can become life-threatening very quickly. From the University of Montreal, sci
Loading Comments...